Edwards Lifesciences Corp — Director's Dealing 2021

May 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-17

Reporting Person: Lemercier Jean-Luc M (CVP, EMEA, Canada, Latin Amer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-17	Common Stock	M	10631.0000	—	Acquired	152828.1380	Direct
2021-05-17	Common Stock	F	143.0000	$89.4900	Disposed	152685.1380	Direct
2021-05-17	Common Stock	F	623.0000	$89.4900	Disposed	152062.1380	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-17	Performance Rights	$	M	10631.0000	Disposed	2025-05-16	Common Stock (10631.0000)	Direct

Footnotes

F1: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4.